Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes (IMAGE)

Deutsches Zentrum fuer Diabetesforschung DZD

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes

Caption

The diabetes drug empagliflozin normalizes insulin action in the brain, improves fasting glucose levels, lowers liver fat and reduces body fat. © DZD

Credit

DZD

Usage Restrictions

no

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.